Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification

Cummings JL, Osse AML, Kinney JW.

Drugs. 2023 Oct;83(15):1387-1408. doi: 10.1007/s40265-023-01938-w. Epub 2023 Sep 20.

Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants

Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J.

Alzheimers Res Ther. 2023 Oct 13;15(1):175. doi: 10.1186/s13195-023-01314-6.

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Khalifa AA, Saad HM, Batiha GE.

J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.

Accelerating Alzheimer's therapeutic development: The past and future of clinical trials

Boxer AL, Sperling R.

Cell. 2023 Oct 26;186(22):4757-4772. doi: 10.1016/j.cell.2023.09.023. Epub 2023 Oct 16.

ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients

Oosthoek M, Lili A, Almeida A, van Loosbroek O, van der Geest R, de Greef-van der Sandt I, van Bokhoven P, Sikkes SAM, Teunissen CE, Vijverberg EGB.

J Prev Alzheimers Dis. 2023;10(4):669-674. doi: 10.14283/jpad.2023.107.

The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging

Owen M, Bose N, Nisenbaum L, Partrick KA, Fillit HM.

J Prev Alzheimers Dis. 2023;10(4):729-742. doi: 10.14283/jpad.2023.111.

Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial

Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, Li Y, Lin L, DuBois J, Hutchison RM, Ziogas N, Shulman M, Martarello L, Graham D, Lane R, Budd Haeberlein S, Beaver J.

JAMA Neurol. 2023 Dec 1;80(12):1344-1352. doi: 10.1001/jamaneurol.2023.3861.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Potential Retinal Biomarkers in Alzheimer's Disease

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M.

Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834.

Clusterin is a Potential Therapeutic Target in Alzheimer's Disease

Palihati N, Tang Y, Yin Y, Yu D, Liu G, Quan Z, Ni J, Yan Y, Qing H.

Mol Neurobiol. 2024 Jul;61(7):3836-3850. doi: 10.1007/s12035-023-03801-1. Epub 2023 Nov 29.

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.

Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.

Massive Weight Loss From Rivastigmine Patch in an Older Patient: A Rare Case

Naharci MI, Veizi BGY, Katipoglu B, Akcan E, Yoruk F, Tasci I.

J Clin Psychopharmacol. 2022 Mar-Apr 01;42(2):222-224. doi: 10.1097/JCP.0000000000001254.

Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease

Iqubal A, Iqubal MK, Fazal SA, Pottoo FH, Haque SE.

Curr Mol Pharmacol. 2022;15(1):23-50. doi: 10.2174/1874467214666210309115605.

Roles of Cannabidiol in the Treatment and Prevention of Alzheimer's Disease by Multi-target Actions

Zhang XB, Li J, Gu J, Zeng YQ.

Mini Rev Med Chem. 2022;22(1):43-51. doi: 10.2174/1389557521666210331162857.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias